Filing Details

Accession Number:
0000912282-24-000461
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-05-28 14:56:52
Reporting Period:
2024-05-23
Accepted Time:
2024-05-28 14:56:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509261 Rezolute Inc. RZLT Pharmaceutical Preparations (2834) 273440894
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1829608 Kenneth Brian Roberts C/O Rezolute, Inc.
275 Shoreline Drive, Suite 500
Redwood City CA 94065
Chief Medical Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Acquisiton 2024-05-23 1,500 $2.72 44,052 No 4 P Direct
Common Shares Acquisiton 2024-05-23 6,000 $2.68 50,052 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Shares 10,000 Indirect Held in IRA
Common Shares 1,076 Indirect Held by minor child